生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Econazole is an antifungal agent and a new PI3K (phosphatidylinositol-3-kinase) inhibitor and a potential drug that can be used in lung cancer treatment alone or in combination with cisplatin. Econazole significantly suppressed A549 tumor growth in nude mice[3]. Guinea-pigs infected with T. mentagrophytes, M. canis or C. albicans and treated topically or orally with econazole, were cured. In each of these tests the activity of econazole was compared with that of different reference drugs. Vaginal candidiasis in rats was cured after oral administration of econazole. Toxicity and teratogenicity studies in different laboratory animals indicate that econazole is well tolerated[4]. The econazole-bound TRPV5 (transient receptor potential vanilloid 5) structure adopts a closed conformation with a distinct lower gate that occludes Ca2+ permeation through the channel[5]. Moreover, econazole nitrate loaded transethosomes are effective to deliver econazole nitrate transdermally in a controlled fashion for effective elimination of cutaneous candidiasis[6]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00385502 | Onychomycosis | Phase 2 | Unknown | June 2008 | United States, Arizona ... 展开 >> Tucson, Arizona, United States, 85741 United States, New York New York, New York, United States, 10032 United States, Oregon Portland, Oregon, United States, 97210 收起 << |
NCT03129321 | Tinea Pedis | Phase 3 | Completed | - | - |
NCT03129321 | - | Completed | - | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.62mL 0.52mL 0.26mL |
13.10mL 2.62mL 1.31mL |
26.20mL 5.24mL 2.62mL |
参考文献 |
---|